166 related articles for article (PubMed ID: 25838434)
1. A Combination of Screening and Computational Approaches for the Identification of Novel Compounds That Decrease Mast Cell Degranulation.
McShane MP; Friedrichson T; Giner A; Meyenhofer F; Barsacchi R; Bickle M; Zerial M
J Biomol Screen; 2015 Jul; 20(6):720-8. PubMed ID: 25838434
[TBL] [Abstract][Full Text] [Related]
2. A phenotypic screening approach in cord blood-derived mast cells to identify anti-inflammatory compounds.
Kaur R; Sloan LA; Blanchard AD; Smith JL; Churcher I; Wayne GJ; Ludbrook SB
J Biomol Screen; 2013 Dec; 18(10):1223-33. PubMed ID: 23983232
[TBL] [Abstract][Full Text] [Related]
3. Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release.
Suzuki Y; Yoshimaru T; Yamashita K; Matsui T; Yamaki M; Shimizu K
Biochem Biophys Res Commun; 2001 May; 283(3):707-14. PubMed ID: 11341783
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
Passante E; Ehrhardt C; Sheridan H; Frankish N
Inflamm Res; 2008; 57 Suppl 1():S15-6. PubMed ID: 18345510
[No Abstract] [Full Text] [Related]
5. In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells.
Naal RM; Tabb J; Holowka D; Baird B
Biosens Bioelectron; 2004 Nov; 20(4):791-6. PubMed ID: 15522594
[TBL] [Abstract][Full Text] [Related]
6. The role of actin microfilaments in the down-regulation of the degranulation response in RBL-2H3 mast cells.
Frigeri L; Apgar JR
J Immunol; 1999 Feb; 162(4):2243-50. PubMed ID: 9973500
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells.
Matsubara M; Masaki S; Ohmori K; Karasawa A; Hasegawa K
Biochem Pharmacol; 2004 Apr; 67(7):1315-26. PubMed ID: 15013847
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intracellular calcium levels and inhibition of degranulation in RBL-2H3 mast cells by the sesquiterpene lactone parthenolide.
Hong J; Aoyama S; Hirasawa N; Zee O; Ishihara K; Hashida C; Kimura M; Seyama T; Ohuchi K
Planta Med; 2011 Feb; 77(3):252-6. PubMed ID: 20814853
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening.
Choi HW; Chan C; Shterev ID; Lynch HE; Robinette TJ; Johnson-Weaver BT; Shi J; Sempowski GD; Kim SY; Dickson JK; Gooden DM; Abraham SN; Staats HF
SLAS Discov; 2019 Jul; 24(6):628-640. PubMed ID: 30917061
[TBL] [Abstract][Full Text] [Related]
10. Effects of flavone derivatives on antigen-stimulated degranulation in RBL-2H3 cells.
Hwang D; Park HJ; Seo EK; Oh JY; Ji SY; Park DK; Lim Y
Chem Biol Drug Des; 2013 Feb; 81(2):228-37. PubMed ID: 23035634
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial agent triclosan suppresses RBL-2H3 mast cell function.
Palmer RK; Hutchinson LM; Burpee BT; Tupper EJ; Pelletier JH; Kormendy Z; Hopke AR; Malay ET; Evans BL; Velez A; Gosse JA
Toxicol Appl Pharmacol; 2012 Jan; 258(1):99-108. PubMed ID: 22036726
[TBL] [Abstract][Full Text] [Related]
12. Effects of propolis from different areas on mast cell degranulation and identification of the effective components in propolis.
Nakamura R; Nakamura R; Watanabe K; Oka K; Ohta S; Mishima S; Teshima R
Int Immunopharmacol; 2010 Sep; 10(9):1107-12. PubMed ID: 20601180
[TBL] [Abstract][Full Text] [Related]
13. Suppression of adenosine A(3) receptor-mediated hypotension and mast cell degranulation in the rat by dexamethasone.
Hannon JP; Tigani B; Schuurman HJ; Fozard JR
J Pharmacol Exp Ther; 2002 Aug; 302(2):725-30. PubMed ID: 12130737
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity phenotypic screening looking to increase OBR cell surface expression.
Kim TH; Choi DH; Vauthier V; Dam J; Li X; Nam YJ; Ko Y; Kwon HJ; Shin SH; Cechetto J; Soloveva V; Jockers R
J Biomol Screen; 2014 Jan; 19(1):88-99. PubMed ID: 23958651
[TBL] [Abstract][Full Text] [Related]
15. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
16. Yeast Ca(2+)-signal transduction inhibitors isolated from Dominican amber prevent the degranulation of RBL-2H3 cells through the inhibition of Ca(2+)-influx.
Abe T; Kobayashi M; Okawa Y; Inui T; Yoshida J; Higashio H; Shinden H; Uesugi S; Koshino H; Kimura K
Fitoterapia; 2016 Sep; 113():188-94. PubMed ID: 27491756
[TBL] [Abstract][Full Text] [Related]
17. Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties.
Gupta K; Kotian A; Subramanian H; Daniell H; Ali H
Oncotarget; 2015 Oct; 6(30):28573-87. PubMed ID: 26378047
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucosamine and related compounds on the degranulation of mast cells and ear swelling induced by dinitrofluorobenzene in mice.
Sakai S; Sugawara T; Kishi T; Yanagimoto K; Hirata T
Life Sci; 2010 Feb; 86(9-10):337-43. PubMed ID: 20093129
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of guarana seed extract on passive cutaneous anaphylaxis and mast cell degranulation.
Jippo T; Kobayashi Y; Sato H; Hattori A; Takeuchi H; Sugimoto K; Shigekawa M
Biosci Biotechnol Biochem; 2009 Sep; 73(9):2110-2. PubMed ID: 19734657
[TBL] [Abstract][Full Text] [Related]
20. Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1.
Kim JW; Inagaki Y; Mitsutake S; Maezawa N; Katsumura S; Ryu YW; Park CS; Taniguchi M; Igarashi Y
Biochim Biophys Acta; 2005 Dec; 1738(1-3):82-90. PubMed ID: 16352467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
